Record Display for the EPA National Library Catalog
RECORD NUMBER: 14 OF 321
|OLS Field Name||OLS Field Data|
|Main Title||A Review of the Scientific Literature As It Pertains to Gulf War Illnesses.|
|ISBN||0585302367; 9780585302362; 0833026763; 9780833026767; 0833026771; 9780833026774; 0833026798; 0833026801; 9780833026804; 0833026682; 083302681X; 0833026828; 0833026836; 9780833026835; 0833027956; 9780833027955; 9780833026798; 9780833026682; 9780833026811; 9780833026828|
|Subjects||Persian Gulf syndrome. ; BUSINESS & ECONOMICS--Human Resources & Personnel Management. ; MEDICAL--Health Policy.|
|Collation||volumes <1-2, 4-8> : illustrations, maps ; 26 cm.|
"Prepared for the Office of the Secretary of Defense, National Defense Research Institute." "MR-1018-OSD." Includes bibliographical references.
The confrontation that began when Iraq invaded Kuwait in August 1990 brought with it the threat that chemical and biological weapons might be used against the more than half a million military personnel the United States deployed to the region. To protect these troops from such threats, the Department of Defense wished to use drugs and vaccines that, not having been tested for use in these specific situations, were considered "investigational" by the federal Food and Drug Administration. This report examines the history of the Interim Rule, adopted in December 21, 1990, that authorized the Commissioner of Food and Drugs to waive informed consent for the use of investigational drugs and vaccines for certain military uses; how this authority was used for pyridostigmine bromide and botulinum toxoid during the Gulf War; and the subsequent controversy surrounding the rule, its application, and its implications.